Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy

SIMPLE SUMMARY: Patients with high-risk acute leukemias and lymphomas undergo stem cell transplantation or cellular therapies to achieve a cure. These are complex treatments that are typically offered by specialty medical centers. Patients are treated and monitored in the hospital for 3–4 weeks due...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Arpita P., Lee, Catherine J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452361/
https://www.ncbi.nlm.nih.gov/pubmed/37627136
http://dx.doi.org/10.3390/cancers15164108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452361/
https://www.ncbi.nlm.nih.gov/pubmed/37627136
http://dx.doi.org/10.3390/cancers15164108

Ejemplares similares